Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Helicobacter Pylori

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Helicobacter

Šterbenc A, Vratanar B, Mojškerc EM, Homan M

doi: 10.1111/hel.70103

Helicobacter Pylori

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial

Helicobacter

El-Azab G, Abdel Salam S, Moustafa E, Abuoelhassan A, Shamseya A, Ellakany A, Abdelaal U, Assem M, Khalil F, Mahmoud A, Elsabaawy M, Hussein B, Ezz-Eldin M, Hassany S, Zaghloul N, Magdy M

doi: 10.1111/hel.70104

Helicobacter Pylori

Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial

Helicobacter

Wei S, Huang Z, Xiong H, Wu J, Mei D, Zhao J, Liu W, Liu Q, Lin Y, Liu F, Peng X, Chen H

doi: 10.1111/hel.70100

Helicobacter Pylori

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial

Helicobacter

Yan TL, Wang JH, Zhu RK, Zhai HL, Wang ZZ, Mao XL, Shen X, Xu P, Ma D, He XJ, Wang JW, Gao JG, Jiang LL, Sun K, Chen Y, Sang JZ, Liu XQ, Chen JE, Li L

doi: 10.1111/hel.70056

Helicobacter Pylori

Optimizing Duration and Dosing Frequency of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial

Helicobacter

Tao L, Qian H, Zhang L, Luo P, Ma S, Yan J, Liu Y, Chen M, Tao Y, Shi J, Zhang G, Ye F

doi: 10.1111/hel.70062

Helicobacter Pylori

Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study

Helicobacter

Cho YS, Kim SM, Kang SH, Moon HS, Sung JK, Bang KB, Ryou SH, Kim KB, Sul HJ, Lee SW

doi: 10.1111/hel.70040

Helicobacter Pylori

Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial

Gastroenterology

Gao W, Li J, Yang G, Du S, Ling T, Zhang X, Ye H, Xiong Y, Tian Y, Liu J, Liu B, Wang C, Cheng H

doi: 10.1053/j.gastro.2026.01.008

Inflammatory Bowel Disease

Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD)

Inflamm Bowel Dis

Ter Avest MM, Huijbers MJ, Horjus CS, Römkens TEH, Witteman EM, van Dop WA, Dresler M, Donders ART, Dijkstra G, Nissen LHC, Speckens AEM

doi: 10.1093/ibd/izaf116

Helicobacter Pylori

Second- and Third-Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013-2023 of the European Registry on H. pylori Management

Helicobacter

Tepes B, Denkovski M, Jurecic NB, Tepes K, Cano-Català A, Parra P, Moreira L, Nyssen OP, Mégraud F, O'Morain C, Gisbert JP

doi: 10.1111/hel.70085

Related content

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial

Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial

Optimizing Duration and Dosing Frequency of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial

Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study

Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial

Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD)

Second- and Third-Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013-2023 of the European Registry on H. pylori Management